Overview

Use of Risperidone in ECT for Treatment Resistant Depression

Status:
Terminated

Trial end date:
2006-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if the combination of risperidone and ECT improves a patient's response in depression compared to ECT alone.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, Los Angeles

Collaborator:

Janssen, LP

Treatments:

Risperidone